ALEXANDRIA, Va., July 16 -- United States Patent no. 12,356,994, issued on July 15, was assigned to UNIVERSITY OF VIRGINIA PATENT FOUNDATION (Charlottesville, Va.).
"Antipathogenic polypeptides" was invented by Bryan W. Berger (Charlottesville, Va.) and Evan L Eckersley (Charlottesville, Va.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Antipathogenic polypeptides and related compounds and compositions that display antipathogenic activity, antifungal activity (i.e., act as fungicides), antialgal activity (i.e., act as algaecides), and/or enzymatic activity against chitin (i.e., degrade chitin) and/or polyglucuronic acid (i.e., degrade the polyglucuronic acid) are described. These antipathogenic polypeptides...